{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013491","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.210627+00:00","generated_at":"2026-05-20T01:57:45.198110+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Biofrontera supplements proxy statement reclassifying two proposals as routine matters for broker voting","bullets":["NYSE determined Proposal Nos. 2 and 3 are routine; brokers may vote without instructions, reversing earlier disclosure.","Proposal No. 2 increases authorized common shares from 35M to 70M; Proposal No. 3 is an adjournment measure.","Proxies already received remain valid unless revoked; annual meeting still set for June 12, 2025.","Only Proposal No. 4 (ratification of auditor) was previously listed as routine in the original proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013491","json":"https://secwatch.observer/filing/0001641172-25-013491.json","markdown":"https://secwatch.observer/filing/0001641172-25-013491.md","text":"https://secwatch.observer/filing/0001641172-25-013491.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/0001641172-25-013491-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:57:45.198110+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}